Uncategorized
Merus Stock Surges Over 35% On Strong Phase 2 Cancer Trial Results: What’s Going On?
Merus N.V. (NASDAQ: MRUS) shares are trading higher Friday after the company reported promising interim results from its ongoing phase 2 trial evaluating petosemtamab in combination with pembrolizumab for head and neck cancer. read more
Analog Devices Powers Past Estimates, But Shares Cool As Q2 Beat Masks Margin Pressure
Analysts raise ratings & price targets for Analog Devices after strong fiscal Q2 results & optimistic outlook. Industrials show solid recovery. Latest Ratings for ADI Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Citigroup Maintains Buy Jan 2022 Barclays Maintains Overweight View More Analyst Ratings for ADI View the Latest…
ASP Isotopes (ASPI) Stock Rises On TerraPower Deal And US Nuclear Policy Momentum
ASPI shares surged on a $22 million TerraPower loan and critical uranium supply agreements. Trump’s expected nuclear energy policy also fueled broader sector enthusiasm. read more
Trump Sparks Uranium Frenzy: Nuclear ETFs See Explosive Gains
Uranium and nuclear-themed ETFs surged on news of Trump’s policy backing for the nuclear industry. The top performer was Global X Uranium ETF (URA), up 10%, while other ETFs like North Shore Global Uranium Mining ETF (URNM) and VanEck Uranium+Nuclear Energy ETF (NLR) also saw strong gains. This rally is driven by the potential for…
Autodesk Outlook Is Conservative But Macro Environment Is Still A Wildcard: Analyst
Autodesk (NASDAQ: ADSK) reported better-than-expected Q1 results, raised FY26 guidance, and was rerated by analysts on Wall Street. Latest Ratings for ADSK Date Firm Action From To Feb 2022 Deutsche Bank Maintains Buy Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Rosenblatt Maintains Buy View More Analyst Ratings for ADSK View the Latest Analyst Ratings…
